Stockholders approve OneMedNet merger; $17.9M redeemed, trust drops to ~$1.1M

Proposal 6 : To approve the 2022 Equity Incentive Plan (the “Incentive Plan Proposal”). The voting results for the Incentive Plan Proposal were as follows: For Against Abstain 4,520,354 170,211 0

Proposal 4B : To approve the addition to the Company’s Certificate of Incorporation of a super majority voting requirement (the “Article Amendment Requirement”) to amend Articles V (Board of Directors), VI (Stockholders), VII (Liability and Indemnification; Corporate Opportunity), VIII (Business Combinations), IX (Exclusive Forum), and Article X (Amendments) of the Third Amended and Restated Certificate of Incorporation. The voting results for the Article Amendment Requirement were as follows: For Against Abstain 4,520,354 170,211 0

Proposal 4 : To approve the Third Amended and Restated Certificate of Incorporation, which shall become effective upon the closing of the Business Combination (the “Charter Amendment Proposal”), including (i) the addition of a supermajority voting requirement to amend the Surviving Corporation’s Bylaws, and (ii) the addition of a supermajority voting requirement to amend Articles V (Board of Directors), VI (Stockholders), VII (Liability and Indemnification; Corporate Opportunity), VIII (Business Combinations), IX (Exclusive Forum), and Article X (Amendments) to the Third Amended and Restated Certificate of Incorporation. The voting results for the Charter Amendment Proposal were as follows: For Against Abstain 4,520,354 170,211 0

Proposal 5 : To elect eight directors to serve on the Company’s board of directors following the consummation of the Business Combination until the 2024 annual meeting of Stockholders, in the case of Class I directors, the 2025 annual meeting of Stockholders, in the case of Class II directors, and the 2026 annual meeting of Stockholders, in the case of Class III directors, and, in each case, until their respective successors are duly elected and qualified (the “Director Election Proposal”). The voting results for the Director Election Proposal were as follows: Director For Withheld Erkan Akyuz (Class I) 4,685,885 4,680 Eric Casaburi (Class I) 4,685,885 4,680 Dr. Julianne Huh (Class II) 4,685,885 4,680 Paul Casey (Class II) 4,685,885 4,680 Dr. Thomas Kosasa (Class II) 4,685,885 4,680 Dr. Jeffrey Yu (Class III) 4,525,916 164,649 Robert Golden (Class I) 4,685,885 4,680 R. Scott Holbrook (Class III) 4,685,885 4,680

Proposal 7 : To approve adjourning the Special Meeting to a later date or dates, if necessary to permit further solicitation and vote of proxies if it is determined by the Company that more time is necessary or appropriate to approve one or more Proposals at the Special Meeting (the “Adjournment Proposal”). The voting results for the Adjournment Proposal were as follows: For Against Abstain 4,680,323 10,242 0

Proposal 4A : To approve the addition to Company’s Certificate of Incorporation of a super majority voting requirement to amend the Surviving Corporation’s Bylaws (the “Bylaw Amendment Requirement”), as contained in the Third Amended and Restated Certificate of Incorporation. The voting results for the Bylaw Amendment Requirement were as follows: For Against Abstain 4,520,354 170,211 0

Proposal 2 : To approve and adopt the Merger Agreement and approve the transactions contemplated thereby (the “Business Combination Proposal”). The voting results for the Business Combination Proposal were as follows: For Against Abstain 4,680,323 10,242 0

Proposal 1 : To approve an amendment to the Second Amendment to the Second Amended and Restated Certificate of Incorporation (the “Charter”) effective prior to the consummation of the Business Combination, to remove from the Charter the redemption limitation contained under Section 9.2(a) preventing the Company from closing a business combination if it would have less than $5,000,0001 of net tangible assets (the “NTA Proposal”). The voting results for the NTA Proposal were as follows: For Against Abstain 4,590,735 5,562 0

Proposal 3 : To approve, for purposes of complying with Nasdaq Listing Rules 5635(a) and (b), the issuance of more than 20% of the issued and outstanding Class A common stock and the resulting change in control in connection with the Business Combination (the “Nasdaq Proposal”). The voting results for the Nasdaq Proposal were as follows: For Against Abstain 4,680,323 10,242 0